DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20200763

Study of renal functions in metabolic syndrome and its correlation with various parameters

Anand N., Vidya T. A.

Abstract


Background: Metabolic syndrome includes a constellation of various metabolic abnormalities that have been associated with cardiovascular disease, stroke and all-cause mortality in the general population. It has now been established that it is also associated with renal dysfunction. This study was done to assess renal function in metabolic syndrome in Indian population as well as its correlation with different parameters of the metabolic syndrome.

Methods: A cross-sectional study was conducted in a university hospital from 2014 - 2015. Renal functions were studied in 100 obese individuals, 50 with and 50 without metabolic syndrome after informed consent and the results were analysed.

Results: 100 obese individuals, 50 with and 50 without metabolic syndrome were compared. All underwent a physical examination and relevant investigations. All parameters of renal function showed significant derangement in cases as compared to controls. 38 patients (76%) among the cases (N=50) of metabolic syndrome had altered renal functions versus 9 patients (18%) among controls (n=50). Individually, there was a significant correlation of altered renal function (reduced estimated glomerular filtration rate eGFR and presence of microalbuminuria) with fasting blood glucose and systolic blood pressure (p=0.001), diastolic pressure (p=0.003) and triglyceride levels (p=0.036). High density lipoprotein-cholesterol levels did not show a significant correlation.

Conclusions: Obese individuals with metabolic syndrome have significant derangement of renal functions as compared to those without metabolic syndrome. Most parameters of the syndrome are also independently associated with alteration of renal functions.


Keywords


Chronic kidney disease, eGFR, Microalbuminuria, Metabolic syndrome

Full Text:

PDF

References


George SA, Zimmet P, Shaw Z, Scott M. IDF worldwide definition of the metabolic syndrome, IDF, 2006. Available at: http:// www. idf. org/ webdata/docs/IDF_Meta_def_final.pdf. Accessed on 2 September 2013.

Olufadi R, Byrne CD. Clinical and laboratory diagnosis of the metabolic syndrome. J Clin Pathol. 2008;61(6):697-706.

Wisse BE. The inflammatory syndrome: The role of adipose tissue cytokines in metabolic disorders linked to obesity. JASN. 2004;15(11):2792-800.

Wolf G, Chen S, Han DC, Ziyadeh FN. Leptin and renal disease. Am J Kidney Dis. 2002;39:1-11.

Hales CN, Ozanne SE. For debate: fetal and early postnatal growth restriction lead to diabetes, the metabolic syndrome and renal failure. Diabetologia. 2003;46:1013-9.

Hall JE, Brands MW, Henegar JR. Mechanisms of hypertension and kidney disease in obesity. Ann N Y Acad Sci. 1999;892:91-107.

Masuzaki H, Yamamoto H, Kenyon CJ, Elmquist JK, Morton NM, Paterson JM, et al. Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. J Clin Invest. 2003;112:83-90.

Schelling JR, Sedor JR. The metabolic syndrome as a risk factor for chronic kidney disease: more than a fat chance? JASN. 2004;15(11):2773-4.

Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation modification of diet in renal disease study group. Annals Int Med. 1999;130(6):461-70.

Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National health and nutrition examination survey. JAMA. 2002;287:356-9.

Thiruvagounder M, Khan S, Sheriff DS. The prevalence of metabolic syndrome in a local population in India. Biochemia Medica. 2010;20(2):249-52.

Singh AK, Kari JA. Metabolic syndrome and chronic kidney disease. Curr Opin Nephrol Hypertens. 2013;22(2):19.

Chen J, Gu D, Chen CS, Wu X, Hamm LL, Muntner P, et al. Association between the metabolic syndrome and chronic kidney disease in Chinese adults. Nephrol Dial Transplant. 2007;22:1100-6.

Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol. 2005;16:2134-40.

Othman M, Kawar B, Nahas AM. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study. Nephron Clin Pract. 2009;113:16-23.

Bonnet F, Marre M, Halimi JM, Stengel B, Lange C, Laville M, et al. Waist circumference and the metabolic syndrome predict the development of elevated albuminuria in non-diabetic subjects: the DESIR study. J Hypertens. 2006;24:1157-63.

Sun F, Tao Q, Zhan S. Metabolic syndrome and the development of chronic kidney disease among 118,924 non-diabetic Taiwanese in a retrospective cohort. Nephrology. 2010;15:84-92.

Watanabe H, Obata H, Watanabe T, Sasaki S, Nagai K, Aizawa Y. Metabolic syndrome and risk of development of chronic kidney disease: the niigata preventive medicine study. Diabetes Metab Res Rev. 2010;26:26-32.

Ryu S, Chang Y, Woo HY, Lee KB, Kim SG, Kim DI, et al. Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes. Am J Kidney Dis. 2009;3:59-69.

Wang Q, Chen X, Zhao Y, Gao K, Sun YG, Yang M. Association between metabolic syndrome and chronic kidney disease. Zhonghua Xin Xue Guan Bing Za Zhi. 2008;36(7):618-22.

Palaniappan L, Carnethon M, Fortmann SP. Association between microalbuminuria and the metabolic syndrome: NHANES III. Am J Hypertens. 2003;16(11):952-8.

Li Y, Zhao L, Chen Y, Liu A, Liu X, Shao X, et al. Association between metabolic syndrome and chronic kidney disease in perimenopausal women. Int J Environ Res Public Health. 2013;10(9):3987-97.